BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23013666)

  • 21. The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
    Schiavina R; Ceci F; Borghesi M; Brunocilla E; Vagnoni V; Gacci M; Castellucci P; Nanni C; Martorana G; Fanti S
    Curr Radiopharm; 2013 Jun; 6(2):92-5. PubMed ID: 23597246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.
    Picchio M; Briganti A; Fanti S; Heidenreich A; Krause BJ; Messa C; Montorsi F; Reske SN; Thalmann GN
    Eur Urol; 2011 Jan; 59(1):51-60. PubMed ID: 20869161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choline PET/CT for prostate cancer: main clinical applications.
    Fuccio C; Rubello D; Castellucci P; Marzola MC; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e50-6. PubMed ID: 20800404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT in the diagnosis of recurrent prostate carcinoma: a meta-analysis.
    Ren J; Yuan L; Wen G; Yang J
    Acta Radiol; 2016 Apr; 57(4):487-93. PubMed ID: 25907118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
    Jadvar H
    J Nucl Med; 2011 Jan; 52(1):81-9. PubMed ID: 21149473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    World J Urol; 2015 Nov; 33(11):1749-52. PubMed ID: 25824540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.
    Picchio M; Messa C; Landoni C; Gianolli L; Sironi S; Brioschi M; Matarrese M; Matei DV; De Cobelli F; Del Maschio A; Rocco F; Rigatti P; Fazio F
    J Urol; 2003 Apr; 169(4):1337-40. PubMed ID: 12629355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    Golan S; Sopov V; Baniel J; Groshar D
    J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Zengerling F; Schrader AJ; Schrader M; Jentzmik F
    Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
    Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F
    Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic imaging work-up for disease relapse after radical treatment for prostate cancer: how to differentiate local from systemic disease? The urologist point of view.
    Schiavina R; Brunocilla E; Borghesi M; Vagnoni V; Castellucci P; Nanni C; Ceci F; Gacci M; Martorana G; Fanti S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):310-3. PubMed ID: 23933383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate Cancer Imaging with Novel PET Tracers.
    Lindenberg L; Choyke P; Dahut W
    Curr Urol Rep; 2016 Mar; 17(3):18. PubMed ID: 26874530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [11C]-choline PET/CT in imaging locally advanced prostate cancer.
    Rodari M; Lopci E; Pepe G; Antunovic L; Chiti A
    Nucl Med Rev Cent East Eur; 2011; 14(2):118-9. PubMed ID: 22219155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron-emission tomography in imaging and staging prostate cancer.
    Farsad M; Schiavina R; Franceschelli A; Sanguedolce F; Castellucci P; Bertaccini A; Brunocilla E; Manferrari F; Concetti S; Garofalo M; Rocca C; Borghesi M; Franchi R; Fanti S; Nanni C; Martorana G
    Cancer Biomark; 2008; 4(4-5):277-84. PubMed ID: 18957716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
    Rietbergen DD; van der Hiel B; Vogel W; Stokkel MP
    Nucl Med Commun; 2011 Dec; 32(12):1143-7. PubMed ID: 22045476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 11C-Choline and 18F-FDG PET/CT in the Detection of Occult Prostate Cancer in the Context of a Paraneoplastic Syndrome.
    Jiménez-Bonilla J; Quirce R; Banzo I; Martínez-Rodríguez I; Carril JM
    Clin Nucl Med; 2015 Aug; 40(8):695-6. PubMed ID: 26018697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.